NCT01260922View on ClinicalTrials.gov

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Healthy
Interventions
DRUG

Donepezil Hydrochloride

10 mg Orally Disintegrating Tablet

DRUG

Aricept®

10 mg Orally Disintegrating Tablet

Trial Locations (1)

56721

PRACS Institute, Ltd., East Grand Forks

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01260922 - 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions. | Biotech Hunter | Biotech Hunter